The global medical industry experienced a 1% rise in company filings mentions of 3D printing in Q2 2023 compared with the previous quarter, with the highest share accounted for by Align Technology with 33% year-on-year increase, according to GlobalData’s analysis of over 29 medical company filings. GlobalData’s 3D Printing in Medical Devices – Thematic Intelligence report provides a thorough assessment of how 3D printing is being used across the medical devices value chain, and the current landscape, including medical, technology, regulatory, and macroeconomic trends. Buy the report here.
Notably, 3D printing was one of the most frequently referenced themes in Q2 2023, ranking highest in terms of mentions, ahead of electronic medical record (emr) systems and digital media, according to GlobalData.
Of the top leading companies in the medical industry, Align Technology had the greatest increase in references for 3D printing in Q2 2023, compared with the previous quarter. GlobalData identified four 3D printing-related sentences in the company's filings - 0.3% of all sentences - and an increase of 100% in Q2 2023 compared with Q2 2022. Henry Schein’s mentions of 3D printing rose by 200% to 3.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for 3D printing in Q2 2023 was 88.
For further understanding of GlobalData's 3D Printing in Medical Devices - Thematic Intelligence buy the report here.